Pressure BioSciences, Inc. (PBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0115
0.00 (0.00%)
Feb 26, 2025, 3:00 PM EST
Pressure BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1.5 | 1.98 | 1.73 | 2 | 1.22 | 1.81 | Upgrade
|
| Revenue Growth (YoY) | -25.31% | 14.36% | -13.63% | 64.05% | -32.56% | -26.36% | Upgrade
|
| Cost of Revenue | 1.17 | 1.18 | 2.01 | 0.94 | 0.58 | 1.2 | Upgrade
|
| Gross Profit | 0.32 | 0.8 | -0.28 | 1.06 | 0.64 | 0.61 | Upgrade
|
| Selling, General & Admin | 7.3 | 8.94 | 3.64 | 4.14 | 4.08 | 5.26 | Upgrade
|
| Research & Development | 1.22 | 1.37 | 0.97 | 1.1 | 1.14 | 1.16 | Upgrade
|
| Operating Expenses | 8.52 | 10.3 | 4.61 | 5.25 | 5.22 | 6.42 | Upgrade
|
| Operating Income | -8.2 | -9.5 | -4.9 | -4.19 | -4.59 | -5.81 | Upgrade
|
| Interest Expense | -14.73 | -15.58 | -10.44 | -14.45 | -8.34 | -5.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.29 | -0.26 | 0.01 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -23.21 | -25.34 | -15.33 | -18.64 | -12.93 | -11.09 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.02 | -0 | 0 | -0.46 | 0.5 | 0 | Upgrade
|
| Other Unusual Items | -7.49 | -3.97 | -0.75 | -1.06 | -3.58 | -0.8 | Upgrade
|
| Pretax Income | -30.72 | -29.31 | -16.08 | -20.15 | -16.01 | -11.88 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.22 | Upgrade
|
| Net Income | -30.72 | -29.31 | -16.08 | -20.15 | -16.01 | -11.66 | Upgrade
|
| Preferred Dividends & Other Adjustments | 2.53 | 5.89 | 1.73 | 2.53 | 1.58 | 4.21 | Upgrade
|
| Net Income to Common | -33.25 | -35.2 | -17.8 | -22.69 | -17.58 | -15.87 | Upgrade
|
| Shares Outstanding (Basic) | 37 | 23 | 11 | 7 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 23 | 11 | 7 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 151.14% | 111.03% | 66.63% | 100.85% | 66.24% | 29.82% | Upgrade
|
| EPS (Basic) | -0.89 | -1.51 | -1.61 | -3.42 | -5.32 | -7.98 | Upgrade
|
| EPS (Diluted) | -0.89 | -1.51 | -1.61 | -3.42 | -5.32 | -7.98 | Upgrade
|
| Free Cash Flow | -4.43 | -3.19 | -4.5 | -4.99 | -4.88 | -6.35 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.14 | -0.41 | -0.75 | -1.48 | -3.20 | Upgrade
|
| Gross Margin | 21.56% | 40.43% | -16.46% | 52.94% | 52.25% | 33.86% | Upgrade
|
| Operating Margin | -547.79% | -480.51% | -283.25% | -209.01% | -375.70% | -320.75% | Upgrade
|
| Profit Margin | -2222.18% | -1779.91% | -1029.52% | -1132.93% | -1440.67% | -876.69% | Upgrade
|
| Free Cash Flow Margin | -296.35% | -161.47% | -260.14% | -249.28% | -400.20% | -350.88% | Upgrade
|
| EBITDA | -7.98 | -9.39 | -4.78 | -4.08 | -4.46 | -5.68 | Upgrade
|
| EBITDA Margin | - | - | -276.32% | -203.51% | - | - | Upgrade
|
| D&A For EBITDA | 0.22 | 0.11 | 0.12 | 0.11 | 0.13 | 0.12 | Upgrade
|
| EBIT | -8.2 | -9.5 | -4.9 | -4.19 | -4.59 | -5.81 | Upgrade
|
| EBIT Margin | - | - | -283.25% | -209.01% | - | - | Upgrade
|
| Revenue as Reported | 1.5 | 1.98 | 1.73 | 2 | - | - | Upgrade
|
| Advertising Expenses | - | 0 | 0 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.